Cancer of pharma Industry

Cancer of pharma industry reached $100 billion in annual sales, and could reach $147 billion till 2018 cancer of pharma industry is probably the most prosperous business in the United States. New cancer cases diagnosed and death by cancer reaches 585,720 in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, with a projected 39 percent increase to $173 billion by 2020. Pharma industry for cancer is growing very aggressively with many opportunities.

    Related Conference of Cancer of pharma Industry

    Cancer of pharma Industry Conference Speakers